BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32880707)

  • 21. Cumulative dose of hydroxychloroquine is associated with a decrease of resting heart rate in patients with systemic lupus erythematosus: a pilot study.
    Cairoli E; Danese N; Teliz M; Bruzzone MJ; Ferreira J; Rebella M; Cayota A
    Lupus; 2015 Oct; 24(11):1204-9. PubMed ID: 25852050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Simple dose-escalation regimen for hydroxychloroquine-induced hypersensitivity reaction in patients with systemic lupus erythematosus enabled treatment resumption.
    Takamasu E; Yokogawa N; Shimada K; Sugii S
    Lupus; 2019 Oct; 28(12):1473-1476. PubMed ID: 31575325
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic lupus erythematosus and pregnancy: the challenge of improving antenatal care and outcomes.
    Pastore DEA; Costa ML; Surita FG
    Lupus; 2019 Oct; 28(12):1417-1426. PubMed ID: 31551036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of pregnancy on disease flares in patients with systemic lupus erythematosus.
    Eudy AM; Siega-Riz AM; Engel SM; Franceschini N; Howard AG; Clowse MEB; Petri M
    Ann Rheum Dis; 2018 Jun; 77(6):855-860. PubMed ID: 29463519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic lupus erythematosus pregnancies: the Sarawak experience and review of lupus pregnancies in Asia.
    Teh CL; Wong JS; Ngeh NK; Loh WL
    Rheumatol Int; 2011 Sep; 31(9):1153-7. PubMed ID: 20349069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and Safety of Hydroxychloroquine Therapy for Systemic Lupus Erythematosus Patients Depend on Administration Dose.
    Wakiya R; Kameda T; Nakashima S; Shimada H; Fahmy Mansour MM; Kato M; Miyagi T; Kadowaki N; Dobashi H
    Intern Med; 2020 Sep; 59(17):2105-2112. PubMed ID: 32522920
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reproductive outcomes following hydroxychloroquine use for autoimmune diseases: a systematic review and meta-analysis.
    Kaplan YC; Ozsarfati J; Nickel C; Koren G
    Br J Clin Pharmacol; 2016 May; 81(5):835-48. PubMed ID: 26700396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study.
    Fernandez-Ruiz R; Bornkamp N; Kim MY; Askanase A; Zezon A; Tseng CE; Belmont HM; Saxena A; Salmon JE; Lockshin M; Buyon JP; Izmirly PM
    Arthritis Res Ther; 2020 Aug; 22(1):191. PubMed ID: 32807233
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of hydroxychloroquine in pregnancy and its effect on perinatal outcomes in a population with autoimmune abnormalities.
    Ye S; Zhao X; Liu Y; Ma Y; Wang Y; Zhao J
    Clin Rheumatol; 2023 Apr; 42(4):1137-1150. PubMed ID: 36507975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
    Abarientos C; Sperber K; Shapiro DL; Aronow WS; Chao CP; Ash JY
    Expert Opin Drug Saf; 2011 Sep; 10(5):705-14. PubMed ID: 21417950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of hydroxychloroquine on the gestational outcomes of pregnant women with immune system problems that necessitate the use of the drug.
    Beksac MS; Donmez HG
    J Obstet Gynaecol Res; 2021 Feb; 47(2):570-575. PubMed ID: 33146470
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group.
    Costedoat-Chalumeau N; Amoura Z; Duhaut P; Huong DL; Sebbough D; Wechsler B; Vauthier D; Denjoy I; Lupoglazoff JM; Piette JC
    Arthritis Rheum; 2003 Nov; 48(11):3207-11. PubMed ID: 14613284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Safety of hydroxychloroquine in pregnant patients with connective tissue diseases. Review of the literature.
    Costedoat-Chalumeau N; Amoura Z; Huong DL; Lechat P; Piette JC
    Autoimmun Rev; 2005 Feb; 4(2):111-5. PubMed ID: 15722258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Hydroxychloroquine on Lupus Activity, Preeclampsia and Intrauterine Growth Restriction in Pregnant Women with Systemic Lupus Erythematosus and/or Antiphospholipid Syndrome: A Systematic Review and Meta-Analysis.
    Hu Z; Gao R; Huang W; Wang H; Qin L
    J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675415
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study).
    Costedoat-Chalumeau N; Galicier L; Aumaître O; Francès C; Le Guern V; Lioté F; Smail A; Limal N; Perard L; Desmurs-Clavel H; Boutin du LT; Asli B; Kahn JE; Pourrat J; Sailler L; Ackermann F; Papo T; Sacré K; Fain O; Stirnemann J; Cacoub P; Jallouli M; Leroux G; Cohen-Bittan J; Tanguy ML; Hulot JS; Lechat P; Musset L; Amoura Z; Piette JC;
    Ann Rheum Dis; 2013 Nov; 72(11):1786-92. PubMed ID: 23144449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic lupus erythematosus and pregnancy: A retrospective single-center study of 215 pregnancies from Portugal.
    Braga A; Barros T; Faria R; Marinho A; Carvalheira G; Rocha G; Farinha F; Neves E; Vasconcelos C; Braga J
    Lupus; 2021 Nov; 30(13):2165-2175. PubMed ID: 34693803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuation Rate, Safety and Efficacy of Hydroxychloroquine Treatment in a Retrospective Cohort of Systemic Lupus Erythematosus in a Japanese Municipal Hospital.
    Hosokawa Y; Oiwa H
    Intern Med; 2020 Oct; 59(20):2485-2490. PubMed ID: 32641656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systemic Lupus Erythematosus and Pregnancy.
    Lateef A; Petri M
    Rheum Dis Clin North Am; 2017 May; 43(2):215-226. PubMed ID: 28390564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prospective study of efficacy and safety of hydroxychloroquine in pregnant patients with systemic lupus erythematosus].
    Hao D; Xu D; Liu J; Jin D; Zhao Y; Gao Z
    Zhonghua Yi Xue Za Zhi; 2014 Apr; 94(13):981-3. PubMed ID: 24851683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical impact of hydroxychloroquine dose adjustment according to the American Academy of Ophthalmology guidelines in systemic lupus erythematosus.
    Vázquez-Otero I; Medina-Cintrón N; Arroyo-Ávila M; González-Sepúlveda L; Vilá LM
    Lupus Sci Med; 2020 May; 7(1):. PubMed ID: 32434863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.